Abstract:OBJECTIVE:In order to explore the regulating effects of Egr-1 promoter sequences in transcriptional targeting by 5-fluorouracil (5-Fu) on the expression of hematopoietic growth factor genes.METHODS:The human GM-CSF cDNA and enhanced green fluorescent protein (EGFP) cDNA were linked together with IRES and then inserted into the expression vector pCIneo under control of the Egr-1 promoter (Egr-EG). The vector was transferred into human bone marrow stromal cell line HFCL by lipofectin(TM). The transfected cell clones (HFCL/EG) have been selected by the addition of G418. The cells are exposed to the clinically important anticancer agent 5-fluorouracil. The activity of EGFP in HFCL/EG cells was detected by flow cytometry. The post-chemotherapeutical expression of GM-CSF in HFCL/EG was confirmed with ELISA and Western blot and RT-PCR respectively. The effect of N-acetylcysteine (a free radical scavenger) on GM-CSF production post-exposure to 5-Fu was examined. The HFCL/EG cells were transplanted intravenously into B16 melanoma in C. B-17 combined immunodeficient (SCID) mice. 5-Fu was given i.p. at Day 3. The white blood cell number in peripheral blood, the expression of EGFP and GM-CSF and in human stromal cell engrafted in recipient mice were detected by flow cytometry and RT-PCR respectively. Tumor volume in tumor-bearing mice was calculated.RESULTS:The results indicated that the activity of EGFP and the amounts of secreted GM-CSF in HFCL/EG cells exposed to 5-Fu increased as compared to non-5-Fu group with flow cytometry, RT-PCR and ELISA respectively. N-acetylcysteine significantly decreased the concentration of GM-CSF in HFCL/EG cells treated with 5-FU. In contrast to two control groups, HFCL/EG (Egr-1 regulatory element-derived expression of GM-CSF gene therapy) resulted in a proportionally obvious increase in the number of white blood cell after chemotherapy and no significant difference was found for tumor inhibition in recipient mice.CONCLUSIONS:These in vitro data provide an experimental basis for use of gene therapy of hematopoietic growth factor gene regulated by Egr-1 promoter to protect hematopoiesis from 5-Fu-injury effects.

Therapeutic Effects of Combined Suicide Gene and Granulocyte-Macrophage Colony Stimulating Factor Gene Transfer on Erythroleukemia in Mice

Therapeutic effects of combined suicide gene and cytokine gene therapy on erythroleukemia-bearing mice]

Enhanced antitumor effects of suicide gene therapy by simultaneous transfer of GM-CSF gene in leukemia-bearing mice

Adenovirus-mediated combined suicide gene and interleukin-2 gene therapy for the treatment of established tumor and induction of antitumor immunity

Combination of Suicide Gene and Interleukin 2 Gene Transfer Elicited Potent Antitumor Effects on Murine Melanoma

Enhanced antitumoral effect of adenovirus-mediated cytosine deaminase gene therapy by induction of antigen-presenting cells through stem cell factor/granulocyte-macrophage colony-stimulating factor gene transfer

Augmentation of Antitumor Effect of Adenovirus-Mediated CD Suicide Gene Therapy by Cotransfer of Interleukin 2 Gene in Melanoma-Bearing Mice.

Therapeutic Effect of Combined Treatment with CD Suicide Gene and GM-CSF Gene on Murine Melanoma and Its Immunological Mechanism

Antitumor effect of combined therapy with adenovirus-mediated CD suicide gene and interleukin 2 gene transfer and its immunological mechanism]

Adenovirus-mediated combined P16 gene and GM-CSF gene therapy for the treatment of established tumor and induction of antitumor immunity

Enhancement of Tumor Klling Using a Combination of E. Coli Cytosine Deaminase Gene and INF-#gamma# Gene Therapy

[Effect of Fluorouracil-inducible GM-CSF Gene Therapy Regulated by Egr-1 Promoter on Chemotherapeutic Hematopoietic Damage of Tumor-Bearing Mice].

Therapeutic Effect of YCD Suicide Gene-Modified Murine P388 Leukemia in Vivo

Adenovirus-mediated Tissue-Specific Cytosine Deaminase Gene Therapy for Human Hepatocellular Carcinoma with Different AFP Expression Levels.

[Experimental study of tissue-specific suicide gene therapy for lung adenocarcinoma].

In Vivo Gene Transfer of A Suicide Gene under the Transcriptional Control of the Carcinoembryonic Antigen Promoter Results in Bone Marrow Transduction but Can Avoid Bone Marrow Suppression

Systemic genetic transfer of p21 WAF − 1 and GM-CSF utilizing of a novel oligopeptide-based EGF receptor targeting polyplex

[Anti-Tumor and Bystander Effects of Cationic Liposome-Mediated CD/5-FC Suicide Gene System Combined with Interferon-Gamma in Vivo].

[Killing Effect of Double Suicide Genes Mediated by Retroviral Vector on K562 Cells].

Therapy of Murine Gastric Cancer by 5-FC/CD Suicide Gene System Combined with HSP-PC Tumor Vaccine

In vitro antitumor effect of CD, TK fusion suicide gene induced by adenovirus vector